Adverse Drug Events in children: characterization and follow-up by a clinical pharmacist
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: SOUZA, Cinthia (Unicamp, Unicamp, São Paulo, Brazil)
- Co-author(s): Cinthia Madeira de Souza:|Gabriela Galhardo De Vito:|Ana Carolina Araújo Pimentel:|Caroline Gabriele de Paula:|Daniele Baldini:|Rosiane de Fatima Lopes Ambrosio:|Patricia Moriel:
Children are an important segment of the population; however they are often excluded from clinical trials. As a consequence they may be more vulnerable to adverse drug events (ADEs) because potential harms have not been studied.
A clinical and prospective study was conducted in a Pediatric Emergency Room (ER), during February 2014 to February.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.